15.12.2012 Views

Registration Document - Pernod Ricard

Registration Document - Pernod Ricard

Registration Document - Pernod Ricard

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

6 Presentation<br />

158<br />

COMBINED (ORDINARY AND EXTRAORDINARY) SHAREHOLDERS’ MEETING<br />

of the resolutions<br />

It is proposed that, by voting on the 10th, 11th and 12th resolutions,<br />

you appoint Mr. Gérald Frère, Mr. Michel Chambaud and Mr. Anders<br />

Narvinger as new Directors, replacing Mr. Didier Pineau- Valencienne,<br />

Mr. Gérard Théry and Mr. William H. Webb. The latter, whose terms of<br />

office as Directors expire with this meeting, have decided not to seek<br />

their renewal.<br />

The presentation notices of Mr. Gérald Frère, Mr. Michel Chambaud and<br />

Mr. Anders Narvinger appear in the section “Corporate Governance<br />

and Internal Control” herein.<br />

In accordance with our bylaws, Danièle <strong>Ricard</strong>, Société Paul <strong>Ricard</strong><br />

SA , Jean-Dominique Comolli, Lord Douro, Mr. Gérald Frère, Mr. Michel<br />

Chambaud and Mr. Anders Narvinger would be appointed for a term<br />

of four years expiring at the close of the Shareholders’ Meeting to<br />

be held in 2013 to approve the financial statements for the previous<br />

financial year.<br />

Directors’ fees<br />

The purpose of the 13th resolution is to set the aggregate amount of<br />

Directors’ fees allocated to the Board of Directors for the financial year<br />

in progress at €750,000. This amount is identical to that allocated for<br />

the previous financial year.<br />

Repurchase of shares<br />

As the authorisation granted to the Board of Directors by the<br />

Shareholders’ Meeting on 5 November 2008 to trade in the Company’s<br />

shares is due to expire this year, we propose, in the 14th resolution,<br />

that you renew for a period of 18 months, the authorisation for the<br />

Board of Directors to trade in the Company’s shares at a maximum<br />

purchase price set at €90 per share, excluding acquisition costs.<br />

This authorisation would enable the Board of Directors to purchase<br />

Company shares representing up to 10% of the Company’s share<br />

capital, with a view to:<br />

◆ allocating them to employees and/or D irectors (allocation of call<br />

options and free shares, coverage of its commitments pursuant to<br />

options with cash payments);<br />

◆ using them within the scope of external growth transactions (for<br />

up to 5% of the number of shares comprising the share capital);<br />

◆ delivering shares upon the exercise of rights attached to securities<br />

granting access to the share capital;<br />

◆ cancelling them;<br />

◆<br />

stabilising the share price through liquidity agreements.<br />

It should be noted that during a public offer period concerning<br />

Company shares, repurchasing transactions would only be possible<br />

on the condition, on the one hand, that the offer is settled in cash<br />

and, on the other hand, that it is within the scope of a programme<br />

currently in progress and not likely to cause the offer to fail. In<br />

addition, only repurchases that allow the Company to comply with<br />

its prior commitments would be permitted, i.e. with the objective<br />

of either allowing the Company to implement or cover stock option<br />

programmes or granting of free shares for employees and members<br />

of the Board of the Group, or delivering shares when the right to<br />

securities giving access to the Company’s capital is exercised or<br />

honouring commitments undertaken in the context of external<br />

growth operations that were concluded previously. These operations<br />

would take place under the supervision of the AMF and in compliance<br />

with the conditions of Article 232-17 of its General Regulations.<br />

PERNOD RICARD<br />

Consequently, they could not under any circumstances be anti-takeover<br />

bid (OPA) measures.<br />

Resolutions presented to the<br />

Extraordinary Shareholders’<br />

Meeting<br />

The delegations of authority subject to your vote at this Shareholders’<br />

Meeting cancel and replace, from the date of the Shareholders’ Meeting,<br />

those granted previously and having the same subject.<br />

Reduction of the share capital<br />

by cancelling treasury shares<br />

Among the aims of the share repurchase programme (14th resolution),<br />

features the cancellation of the purchased shares. For this purpose,<br />

we ask you, by voting in favour of the 15th resolution, to authorise<br />

the Board of Directors for a period of 26 months, to cancel all or<br />

some of the Company shares purchased through a share repurchase<br />

programme, for up to 10% of the shares comprising the Company’s<br />

share capital per 24-month period.<br />

Delegations of authority with a view<br />

to issuing ordinary shares or securities<br />

granting access to the Company’s<br />

capital with maintenance of preferential<br />

subscription rights (16th resolution)<br />

or cancellation of preferential subscription<br />

rights (17th resolution)<br />

16th resolution (issues of shares with<br />

preferential subscription rights)<br />

In order to continue its growth strategy and to have at its disposal<br />

means adapted to the Group’s development, your Board of Directors<br />

puts forward resolutions for you to grant it the delegations of authority<br />

for the purpose of issuing securities under current regulations.<br />

The 16th resolution concerns issues, with maintenance of your<br />

preferential subscription right, of your Company’s shares, or<br />

securities granting access to the capital (e.g. convertible bonds, share<br />

warrants).<br />

The maximum nominal amount of the share capital increases likely<br />

to be realised by virtue of this authorisation would be fixed at<br />

€200 million.<br />

It also involves deducting from the Maximum Overall Limit the<br />

share issues determined by virtue of the 17th (issue of securities with<br />

cancellation of the Preferential Subscription Right ), 18th (increase in<br />

the number of securities issued), 19th (compensation of contributions<br />

in kind), 20th (public offer of exchange initiated by the Company),<br />

22nd (capitalisation of reserves) and 25th (share capital increases<br />

reserved for employees) resolutions.<br />

The maximum nominal amount of securities representing debts<br />

(granting access to the capital) on the Company that can be issued by<br />

virtue of this authorisation would be limited to €5 billion.<br />

I REFERENCE DOCUMENT 2008/2009 I

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!